Prenatal administration of thyrotropin releasing hormone (TRH) plus dexamethasone (DEX) to pregnant rats produces significantly depressed fetal lung antioxidant enzyme (AOE) activities and AOE mRNA levels in late gestation. Because of this negative regulation of AOE gene expression in the late fetal lung, we hypothesized that hormonally pretreated prematurely delivered rats might demonstrate inferior tolerance to prolonged hyperoxia. Litters of prenatal TRH+DEX-treated and shamtreated prematurely delivered rat pups (gestational d 21 of 22) were randomized to either >95% O 2 or room air for up to 14 d. The right lungs of 2-and 7-d exposure pups were assayed for AOE activities; the left lungs of the same pups were used to quantitate the concentrations of AOE mRNA by solution hybridization. The prenatal TRH+ DEX-treated pups were able to induce adaptive lung AOE mRNA and activity responses to hyperoxia by 2 d of exposure; and by 7 d in O 2 they showed greater increases in AOE mRNA concentrations and AOE activities in response to hyperoxic challenge compared with the sham-treated controls. Lung lipid surfactant measurements after hyperoxia were not affected by prenatal TRH + DEX treatment. In addition, TRH + DEX-pretreated premature rats did not show the hypothesized increased susceptibility to 02-induced lung damage and lethality, but, in fact, had slightly improved hyperPrenatal hormonal therapy with maternal administration of a combination of TRH and glucocorticoids is now being extensively tested clinically in threatened premature deliveries to try to rapidly stimulate lung maturation and reduce the incidence and severity of respiratory distress syndrome in premature Received May 20, 1994; accepted December 1, 1994 oxic survival (d 3-7 of O 2 exposure) compared with shamtreated controls. Exposure to hyperoxia significantly reduced serum triiodothyronine and thyroxine levels in the sham-control pups. These findings suggest that although TRH + DEXpretreated premature rats have decreased lung AOE gene expression at the time of preterm delivery, subsequent hyperoxic exposure is able to convert AOE gene expression to positive regulation which results in more rapid and greater increases in protective AOE activity levels. This regulation is likely mediated differently for the individual AOE. (Pediatr Res 37: 611-616, 1995) Abbreviations TRH, thyrotropin releasing hormone DEX, dexamethasone AOE, antioxidant enzyme CuZnSOD, copper-zinc superoxide dismutase MnSOD, manganese superoxide dismutase CAT, catalase GP, glutathione peroxidase DSPC, disaturated phosphatidylcholine T3' triiodothyronine T 4 , thyroxine infants (1-3). It has been previously demonstrated by our laboratories that although prenatal administration of TRH +DEX to pregnant rats accelerates surfactant system development in the late fetal lung, this same hormonal treatment significantly decreases the normal fetal lung AOE (SOD, CAT, and GP) activity elevations in late gestation (4). This hormonal effect appears to depend on a pretranslational/ transcriptional mechanism involving decreased AOE mRNA levels (5). When full-term newborn rats prenatally treated with TRH +DEX were exposed to prolonged hyperoxia, results showed that although these newborns manifested lower baseline AOE activities at birth than control term newborns, the 611 612 CHEN ETAL.
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hormone-treated pups were still able to induce an adaptive lung AOE response to hyperoxic exposure of equal or even greater magnitude compared with 0z-exposed control offspring (4) . Moreover, what was most interesting and still unexplained in this previous study was the consistent finding that, despite their greater pulmonary AOE response to hyperoxic challenge, the prenatal TRH + DEX-treated full-term newborn rats showed evidence of decreased hyperoxic survival and Oz tolerance compared with Oz control pups (6) .
Based on these previous findings, we hypothesized that prematurely delivered rat pups prenatally treated with TRH + DEX might likewise demonstrate inferior tolerance to prolonged hyperoxia just as full-term TRH + DEX rat pups did. To test this hypothesis, we used a prematurely delivered rat model (7) which we felt was more reflective of the clinical use of this combined hormonal treatment. We performed studies in which prenatal TRH + DEX-treated and sham-treated control premature rat pups were simultaneously exposed to prolonged hyperoxic exposure and various parameters of relative Oz tolerance/susceptibility were compared between the two groups.
METHODS

Animals and treatment.
Adult breeder Sprague-Dawley albino rats were obtained from Charles River Laboratories (Wellington, MA). Breeding was accomplished by placing two female rats in the same cage with one male overnight. Probable pregnancy was determined by a positive vaginal sperm smear the next morning, and the onset of gestation was considered to be the midpoint of the cohabitation period. The timedpregnancy rats were maintained on standard laboratory food and water ad libitum and were kept on a 12-h light/dark cycle in the accredited University of Miami Animal Care Facilities. All portions of the experimental protocol were preapproved by the University of Miami Animal Research Welfare Committee.
At 48 h before premature delivery at gestational d 21, timed-pregnancy rats were divided at random into hormonal treatment or sham-control groups. For the group receiving prenatal TRH+DEX combination therapy, prenatal TRH (Bachem Inc., Torrance, CA) was administered as a loading dose ofTRH (25 jLglkg, s.c.) at 48 h before premature delivery, immediately after the s.c. implantation of an Alzet osmotic minipump (Alza Corp., Palo Alto, CA) through which continuous TRH was administered (100 jLg/kg/d). In addition, these same dams received prenatal DEX (Steris Laboratories, Inc., Phoenix, AZ) at a dose of 0.4 mg/kg intraperitoneally at 48 and 24 h before premature delivery. The control pregnant rat group received an equivolume s.c. injection of saline instead of TRH, and a "sham" operation using the same ketamine/xylazine anesthesia (ketamine:xylazine, 45 mglkg:5 mglkg, intraperitoneal injection), as well as an equivolume (0.5 mL/100 g) of intraperitoneal saline instead of DEX. All of the above hormonal treatment procedures and dosages of TRH and DEX were identical to those used in previously reported studies from our laboratories (4-6).
At 21 d of gestation (term = 22 d), pregnant rats were anesthetized by intraperitoneal injection of ketamine/xylazine (dose as above) and hysterotomy was performed. The newly delivered pups were rapidly resuscitated by removing the surrounding membranes, drying them vigorously, warming them on heating pads, and applying low flow Oz (~30%) for 30 min. Hyperoxic exposure. Shortly after delivery and stabilization, all the surviving 21-d premature pups of three to five equivalently treated litters were first pooled together and then randomly redistributed to surrogate rat dams that had recently delivered at term. For each group (TRH+ DEX or sham-treated control), one half of the reconstituted litters were placed in >95% Oz exposure chambers and one half remained in room air. Some nonexperimental full-term newborn rat pups (marked by tail snip) were added at 24 hand/or 48 h of exposure when necessary to readjust the litter sizes to 10-12 pups per dam to ensure equal litter sizes for equivalent nutrition. The details of the procedures and conditions of hyperoxic exposures have been previously described (7) . Survival was noted daily during the 14-d exposure period.
Biochemical analyses. Randomly selected 0z-exposed and air-exposed pups from each group were killed by an intraperitoneal overdose of pentobarbital after either 2 or 7 d of exposure. The procedures of lung perfusion have been previously described (7) . The left lungs of two pups were pooled for measuring AOE mRNA concentrations; the right lungs of the same pups were pooled for assaying AOE activities.
AOE mRNA quantitation. The rat complementary RNA for CuZnSOD, MnSOD, CAT, and GP were prepared as previously described (5, 8, 9) . Total nucleic acids were extracted by phenol-chloroform extraction of the left lung tissue homogenate (9) . Quantitation of each AOE mRNA was achieved using the solution hybridization assay of Durnam and Palmiter (10) . Results of the AOE mRNA concentrations were expressed as the specific AOE mRNA molecules per mg DNA.
AOE activity assays. The right lung tissues were homogenized in cold 2.5 mM potassium phosphate buffer (pH 7.8) in an Omni homogenizer (Omni International Inc., Waterbury, CT). The homogenates were centrifuged at 27 000 X g for 45 min at 4°C. The supernatant fractions were then dialyzed overnight against three changes of 50 volumes of 2.5 mM potassium phosphate buffer (pH 7.8) with 0.1 mM EDTA and were subsequently used for analyses of AOE activities using standard spectrophotometric assays for SOD (cytochrome c reduction rate by xanthine-xanthine oxidase) (11), CAT (HzO z consumption rate) (12) , and GP (NADPH oxidation rate with cumene hydroperoxide substrate) (13) . The method of differential cyanide inhibition was used to quantitate cytosolic CuZnSOD and mitochondrial MnSOD activities (14) . All enzyme activities were expressed as activity units per mg DNA. DNA in aliquots of the lung homogenates used for AOE mRNA or for AOE activity was extracted and measured using purified calf thymus DNA (Sigma Chemical Co., St. Louis, MO) as a standard (15) .
Surfactant phospholipids and DSPC. The lipids were extracted from lung homogenates using the method of Bligh and Dyer (16) . A portion of the lipid extracts was used to isolate DSPC according to Mason et al. (17) . The total phospholipids and DSPC content were measured by phosphorus determina-tions in these fraction (18) . A known quantity of 14C_ dipalmitoyl-phosphatidylcholine (DuPont NEN, Boston, MA) was added before lipid extraction to estimate and' correct for sequential losses. Lipids were expressed as mg/mg protein. Protein was measured by the Folin phenol reagent method (19) .
Lung pathologic analyses. Randomly selected animals from each group at 7 and 14 d of exposure were killed as above. Unperfused, uninflated left lung lobes were tied off and removed for assessing lung wet weight/dry weight ratios [80°C oven; lungs dried until constant weight found (72 h)]. For microscopic studies, the right lungs of randomly selected animals at 7 d of exposure were fixed in situ via a tracheal cannula at a constant inflation pressure of 20 em HzO (fixative, 10% buffered formalin). The coded hematoxylin and eosinstained lung sections (right upper, middle, and lower lobes) were examined for pathologic changes by two investigators who were looking for evidence of interstitial, perivascular/ peribronchiolar, and intraalveolar edema, and lung hemorrhage.
Serum hormone assay. Hormone assays for serum T 3 and T 4 were done using specific RIA kits (Incstar Corporation, Stillwater, MN) in TRH + DEX-treated and sham-treated control pups after 14 d of exposure.
Statistical analyses. Comparative survival data and incidence of intraalveolar edema were compared by X Z testing. 
RESULTS
Survival in hyperoxia.
Initial survival at~30 min after premature delivery averaged 77% (330/431, number alive/total number delivered) for sham-treated control rat pups and 78% (272/349) for TRH +DEX-treated rat pups. The composite survival rates of TRH +DEX-treated and sham-treated control premature rat pups during 14 d of hyperoxia are illustrated in Figure 1 . Premature rats pretreated with TRH + DEX did not demonstrate the hypothesized inferior tolerance to hyperoxic challenge but actually had slightly improved Oz survival versus sham-treated control rats between exposure d 3 and 7.
Lung biochemical responses to hyperoxia. The comparative responses of the pulmonary AOE to hyperoxic challenge in the TRH +DEX-treated and sham-treated control premature rat pups are shown in Tables 1 and 2 (at 2 d exposure) and Figures  2 and 3 (at 7 d exposure) . By 2 d in hyperoxia, the prenatal TRH +DEX pups were able to elevate adaptive lung AGE mRNA levels (Table 1 ) and increase their CAT and GP activity response to hyperoxic exposure compared with no significant changes in CAT activity and slightly decreased GP activity in the sham-treated control-Oj pups (Table 2 ). After 7 d in hyperoxia, the four AOE mRNA levels ( Fig. 2) significantly increased in the TRH +DEX group compared with its respective air group and even greater increases in AOE mRNA levels were present in the TRH +DEX Oz group when compared with the sham-treated control-O; group (with the single exception of MnSOD mRNA). The four AGE activities were also consistently greater in the TRH + DEX group than the sham-treated control o, pups (Fig. 3) .
In contrast to the lung AOE data, no significant differences in response to 7 d of hyperoxia were found in lung DSPC content between the TRH +DEX (0.062 ' ± 0.007) and sham- Lung pathologic analyses. The comparative lung wet weight/dry weight ratios (a reflection of pulmon ary edema)
The effects of prenatal hormonal treatment with the combination of TRH plus glucocorticoids on the maturation of the fetal lung and the surfactant system have been tested in both extensive animal studies and recent clinical studies. The clinical trials with combined TRH and glucocorticoid treatment have shown a decreased incidence of chronic lung disease (bronchopulmonary dysplasia) in very-law-birth weight infants , but surprisingly no significant decrease in the incidence or severity of respiratory distress syndrome (2, 3). hyperoxic survival and no greater sensitivity to pulmonary O 2 toxicity than the sham-treated control pups. These discordant results suggest different effects of prenatal hormonal treatment on preterm versus full-term rat pups, because all hormonal treatment procedures and dosages of TRH and DEX were identical for both studies except for the 24-h difference in the tim ing of the gestation al adminis tration of pr en at al TRH +DEX.
The molecular biology studies described herein were undertaken to provide insight into the regulatory mechanism by which hormonal intervention (TRH + DEX) might be controlling the normal gene expression of the protective AOE system under subsequent hyperoxic conditions. Our findings suggest that the regulation of lung AOE gene expression is complex under hyperoxic conditions. The prematurely delivered rats pretreated with TRH + DEX were previously found to have lowered lung AOE gene expression (depressed AOE activities and AOE mRNA levels) at preterm delivery at d 21 (4, 5) . Similarly, when examined at 2 d postnatal age after room air exposure, their pulmonary AOE mRNA levels remained lower in the premature TRH + DEX group compared with the shamtreated group. However, hyperoxic exposure of premature TRH + DEX-treated pups was able to switch AOE gene expression from negative regulation to positive regulation and result in more rapid and even greater increases in protective AOE activity levels than in sham-treated control premature pups exposed to high O 2 , Previous studies from our own laboratories have demonstrated that normal perinatal gene expression of the four AOE is not coordinately regulated (8) . Other studies suggest this is true also under hyperoxic conditions. For example, differential regulation of specific AOE in response to oxidants (21) or to hyperoxia (22) The premature rat model using 21-d gestation rat pups (7) in the present study provides an appropriate model for investigating prenatal TRH and glucocorticoid treatment (relevant to the human clinical prenatal use), especially because the previously reported full-term animal data (6) strongly imply negative effects on hyperoxic tolerance asso ciated with prenatal TRH + DEX treatment. Our original hypothesis in the present study was that premature rat pups prenatally treated with TRH + DEX would demonstrate inferior tolerance to prolonged hyperoxia, similar to what had been found for full-term TRH + DEX-treated rat pups. Unexpectedly, we found that TRH + DEX-pretreated prematurely delivered pups (unlike hormonally treated term newborns) had transiently improved 616 CHEN £TAL. differentially regulated in high 0 2' Our data suggest that AOE gene expression does not appear to be coordinately regulated in the prem ature rat lung under hyperoxic conditions and/or plus hormonal intervention. For example, in the sham-treated premature rat, lung CAT mRNA concentration decreased 11% with hypero xic exposure for 7 d, whereas CAT activity increased 56 %, suggesting a translational!posttransl ational mechanism of CAT gene expression in the premature rat lung exposed to hyperoxia. The very similar GP activit y (102 %) and mRNA (108%) responses to hyperoxia (7 d), however, point to regulation of GP in hyperoxia at a pretranslational level. The effects of prenatal TRH + DEX admini stration on the premature lung AOE responses to hyperoxia seem to indicate activation of other means of regul ation. For example, for the TRH + DEX group, we found that the CAT response to hyperoxia consists of an mRNA increase of 20% and activity increase of 72%, which may represent a combined pretranslational and a translational! posttranslational mechanism of gene expression in this group 's response to hypero xia. This appears to be the case for GP as well in the TRH + DEX group exposed to hyperoxi a (i.e., more complex AOE gene expression responses than in the sham control group). However, more definitive conclusions about the mechanism(s) of AOE gene expression still depend on further studies to determine whether or not comparative AOE mRNA stabilities (half-lives) are also altered under hyperoxic conditions in either or both the sham control and TRH + DEX-treated rat pup lungs.
More needs to be said about the effect of thyroid hormones in influencing sensitivity to 0 2' The findings in the present stud y that exposure to high O 2 significantly reduced serum T 3 and T 4 levels in sham -treated control rats (and even reduced serum T 4 level in the prenatal TRH +DEX-treated O 2 group) are in agreement with the stud y of Galton (24) , which demonstrated a marked fall in the serum concentration of endogenous T 4 and a decrease in T 4-binding activity in serum with hyperoxia. Smith et al. (25) previously reported that feeding desiccated thyroid or injecting T4 to young rats increased the noxious effects of high O 2 exposure. Smith 's results are consistent with the previous full-term newborn rat studies from our laboratories in which prenatal TRH administration produced decreased hyperoxic survival and O 2 tolerance associated with increased serum T 3 and T 4l evels (6) . For premature rat pups in the present study , however, the similar serum T 3 and T 4 increases in prenatal TRH (plus DEX)-treated rats were not associated with inferior tolerance to hyperoxic exposure. These discordant results for the influence of thyroid hormones on O 2 sensitivity, as well as the divergent effects of prenatal hormonal treatment on preterm versus full-term newborn rats would seem to be gestationally related.
Finally, our findings of a positive correlation between the ability to augment AOE gene expression and improved lung tolerance to hyperoxic challenge in our hormonally treated premature animal s may further support the continued clinical use of prenatal TRH and glucocorticoid treatment in threatened premature deliveries with a high likelihood of requiring assisted ventilation with high O 2 therapy. In addition , our data may contribute some understanding of why to date this treatment regimen has had its most pronounced clinical effect on reducing the incidence of bronchopulmonary dysplasia (rather than respiratory distress syndrome).
